Susquehanna International Group’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-90,009
Closed -$75.6K 13972
2025
Q4
$75.6K Buy
+90,009
New +$90.1K ﹤0.01% 11590
2023
Q4
Sell
-10,340
Closed -$13K 13167
2023
Q3
$13K Sell
10,340
-2,023
-16% -$3.64K ﹤0.01% 11690
2023
Q2
$27.9K Buy
+12,363
New +$30K ﹤0.01% 11542
2022
Q2
Sell
-18,582
Closed -$54K 13797
2022
Q1
$54K Buy
+18,582
New +$65.1K ﹤0.01% 12278

Other funds holding RNXT

Susquehanna International Group's RNXT Position: Q1 2026 in Review

Susquehanna International Group sold out of RenovoRx (RNXT) in Q1 2026, closing a stake of 90,009 shares — an estimated $75.6K sold.

Susquehanna International Group first reported a position in RNXT in Q1 2022 and held it in 4 quarters. The position peaked at $75.6K in Q4 2025. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Susquehanna International Group reported no remaining RenovoRx position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 90,009 RenovoRx shares in Q1 2026, an estimated $75.6K.
  • Susquehanna International Group first reported a position in RenovoRx in Q1 2022 and held it in 4 quarters.
  • Susquehanna International Group's RenovoRx position peaked at $75.6K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.